Direkt zum Inhalt

Niebler, Maximilian ; Jarvers, Irina ; Brunner, Romuald ; Kandsperger, Stephanie

Short-chain carnitines in adolescent major depressive disorder: Associations and biomarker potential

Niebler, Maximilian, Jarvers, Irina , Brunner, Romuald und Kandsperger, Stephanie (2025) Short-chain carnitines in adolescent major depressive disorder: Associations and biomarker potential. Journal of Affective Disorders 390, S. 119832.

Veröffentlichungsdatum dieses Volltextes: 16 Jul 2025 06:33
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.77164


Zusammenfassung

Background A growing body of evidence suggests altered short-chain carnitine biology in mental health, notably significantly reduced serum levels of L-Acetyl-carnitine (LAC) in adults with major depressive disorder (MDD). Building on these findings, our biomarker study aimed to investigate potential MDD-associated disruptions in short-chain carnitines within juvenile cohorts. Methods In a ...

Background
A growing body of evidence suggests altered short-chain carnitine biology in mental health, notably significantly reduced serum levels of L-Acetyl-carnitine (LAC) in adults with major depressive disorder (MDD). Building on these findings, our biomarker study aimed to investigate potential MDD-associated disruptions in short-chain carnitines within juvenile cohorts.
Methods
In a cross-sectional analysis with between-group comparison we contrasted a cohort of adolescents with major depressive disorder (n = 38) with healthy controls (n = 38) by assessing peripheral blood levels of free l-carnitine (FC), LAC as well as the LAC/FC ratio and studied associations with psychometrically assessed clinical characteristics. To validate our cohort allocation and thus to corroborate the MDD related specification of our carnitine associated findings by replicating existing evidence towards specific altered endocrine parameters in adolescent MDD, we furthermore obtained morning cortisol, adrenocorticotropin (ACTH) and the cortisol/ACTH ratio.
Results
No significant inter-cohort differences were observed in FC or LAC-levels, but the LAC/FC ratio was significantly elevated in adolescents with depressive disorder (M(HC) = 0.39, SE = 0.02; M(MDD) = 0.47, SE = 0.02; Cohen's d = 0.80; p < 0.001). After controlling for confounders, in linear regression models, MDD cohort assignment emerged as a significant predictor of an elevated LAC/FC ratio (β = 0.432; p = 0.046; corr. R2 = 0.108), as well as reduced FC levels (β = −0.225; p = 0.049; corr. R2 = 0.120). Binominal regression analyses further identified the LAC/FC ratio (B = 7.432; p = 0.010; corr. R2 = 0.381) as a predictive marker for MDD cohort assignment. Overall, the significant alteration in the LAC/FC ratio reinforces the overarching hypothesis of altered carnitine biology in both adolescent and adult individuals with MDD. Whether adolescent MDD represents a partially aberrant molecular pathophysiology compared to adults, or instead reflects an underdeveloped molecular phenotype differentiation, remains an open question for further research.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftJournal of Affective Disorders
Verlag:Elsevier
Band:390
Seitenbereich:S. 119832
Datum6 Juli 2025
InstitutionenMedizin > Lehrstuhl für Kinder- und Jugendpsychiatrie
Identifikationsnummer
WertTyp
10.1016/j.jad.2025.119832DOI
Stichwörter / KeywordsMajor depressive disorder, Adolescents, Biomarkers, L-acetyl-carnitine, HPA-axis
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-771641
Dokumenten-ID77164

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben